Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria
Open Access
- 2 December 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Hypertension Research
- Vol. 34 (2), 268-273
- https://doi.org/10.1038/hr.2010.221
Abstract
Benidipine inhibits both L- and T-type Ca channels, and has been shown to dilate the efferent arterioles as effectively as the afferent arterioles. In this study, we conducted an open-label and randomized trial to compare the effects of benidipine with those of amlodipine on blood pressure (BP), albuminuria and aldosterone concentration in hypertensive patients with mild-to-moderate stage chronic kidney disease (CKD). Patients with BP130/80 mm Hg, with estimated glomerular filtration rate (eGFR) of 30–90 ml min−1 per 1.73 m2, and with albuminuria>30 mg per g creatinine (Cr), despite treatment with the maximum recommended dose of angiotensin II receptor blockers (ARBs) were randomly assigned to two groups. Patients received either of the following two treatment regimens: 2 mg per day benidipine, which was increased up to a dose of 8 mg per day (n=52), or 2.5 mg per day amlodipine, which was increased up to a dose of 10 mg per day (n=52). After 6 months of treatment, a significant and comparable reduction in the systolic and diastolic BP was observed in both groups. The decrease in the urinary albumin to Cr ratio in the benidipine group was significantly lower than that in the amlodipine group. Although plasma renin activity was not different in the two groups, plasma aldosterone levels were significantly decreased in the benidipine group. Moreover, urinary Na/K ratio was significantly decreased in the benidipine group but remained unchanged in the serum. It may be concluded that benidipine results in a greater reduction of plasma aldosterone and albuminuria than amlodipine, and that these effects are independent of BP reduction.Keywords
This publication has 34 references indexed in Scilit:
- Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3–5 chronic kidney diseaseHypertension Research, 2009
- The Japanese Society of Hypertension Committee for Guidelines for the Management of HypertensionHypertension Research, 2009
- Ca 2+ Channel Subtypes and Pharmacology in the KidneyCirculation Research, 2007
- Inhibitory Effect of Efonidipine on Aldosterone Synthesis and Secretion in Human Adrenocarcinoma (H295R) CellsJournal of Cardiovascular Pharmacology, 2006
- The role of renin-angiotensin-aldosterone system in the progression of chronic kidney diseaseKidney International, 2005
- Pleiotropic Actions of Aldosterone and the Effects of Eplerenone, a Selective Mineralocorticoid Receptor AntagonistHypertension Research, 2004
- Molecular Physiology of Low-Voltage-Activated T-type Calcium ChannelsPhysiological Reviews, 2003
- Overview of Voltage-Dependent Calcium ChannelsJournal of Bioenergetics and Biomembranes, 1998
- The hyperfiltration theory: A paradigm shift in nephrologyKidney International, 1996
- Aldosterone: The minority hormone of the adrenal cortexSteroids, 1995